Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution (2010)

Author(s): Chakraverty R, Orti G, Roughton M, Shen J, Fielding A, Kottaridis P, Milligan D, Collin M, Crawley C, Johnson P, Clark A, Parker A, Bloor A, Pettengell R, Snowden J, Pettitt A, Clark R, Hale G, Peggs K, Thomson K, Morris E, Mackinnon S

      • Date: 29-06-2010
      • Journal: Blood
      • Volume: 116
      • Issue: 16
      • Pages: 3080-3088
      • Publisher: American Society of Hematology
      • Publication type: Article
      • Bibliographic status: Published

      Keywords: Chronic lymphocytic leukemia; Versus-host-disease; Population pharmacokinetics; Alloceneic transplantation; Cytomegalovirus infection; Adoptive immunotherapy; T cells; Campath-1H; Regimen; Antibodies